Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...

The Bank of Bahrain and Kuwait (BBK), a premier retail and commercial bank in the Kingdom, has announced an exciting lineup ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2025 Unplugged Medtech and Life ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into ...